Skip to content

Investigation of the Effect of Self-reported Medication Adherence Tracking Using Common Messaging Applications on Medication Adherence

Investigation of the Effect of Self-reported Medication Adherence Tracking Using Common Messaging Applications on Medication Adherence - Investigation of the Effect of Self-reported Medication Adherence Tracking Using Common Messaging Applications on Medication Adherence

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000056849
Enrollment
20
Registered
2025-02-01
Start date
2025-05-30
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic mental illness

Interventions

The intervention in this study involves providing a therapeutic application in the form of a LINE-based messaging app to patients with chronic psychiatric disorders who are receiving outpatient pharma

Sponsors

Medical Corporation Kokokara
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The study participants include adult patients (aged 18 or older) with chronic psychiatric disorders who are receiving treatment at our hospital and who can fully understand the study protocol and provide consent independently.

Exclusion criteria

Exclusion criteria: Patients who cannot fully understand the research content and those deemed inappropriate for study participation by the researchers will be excluded. The study participation will also be terminated if a participant withdraws their consent after enrollment.

Design outcomes

Primary

MeasureTime frame
Improvement in Medication Adherence

Countries

Japan

Contacts

Public ContactRyohei Matsumoto

Medical Corporation Kokokara Psychiatry

rmatsumoto@kokokara.or.jp0744-47-2100

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026